Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check3 days agoChange DetectedA government funding notice about site status was added and the revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoChange DetectedAdded 'Show glossary' option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous wording.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check38 days agoChange DetectedThe Study Details page appears unchanged. No edits to trial design, eligibility criteria, outcomes, or listed locations were detected.SummaryDifference0.1%

- Check45 days agoChange DetectedA new Locations section has been added, listing the participating sites by state (Arizona, California, Indiana, Maryland, Pennsylvania, Virginia). The page revision shows an update to v3.3.3.SummaryDifference0.8%

- Check53 days agoChange DetectedMinor UI/layout adjustments observed between the two screenshots; core study details such as eligibility criteria, locations, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.